Trials / Sponsors / Shanghai Longyao Biotechnology Inc., Ltd.
Shanghai Longyao Biotechnology Inc., Ltd.
Academic / Other · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | An Evaluation of LY007 Cell Injection for r/r B-NHL B-NHL | Phase 1 | 2021-12-25 |
| Unknown | A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adeno Advanced Gastric Adenocarcinoma | EARLY_Phase 1 | 2021-11-01 |
| Unknown | Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer Pancreatic Cancer | EARLY_Phase 1 | 2021-08-01 |
| Unknown | The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma Relapsed and Refractory B Cell Lymphoma, Non-Hodgkin Lymphoma | EARLY_Phase 1 | 2019-11-22 |
| Unknown | The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) B-cell Acute Lymphoblastic Leukemia (B-ALL), Safety and Efficacy of CD19 UCAR-T Cells | EARLY_Phase 1 | 2019-11-08 |
| Unknown | Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma Recurrent or Refractory B Cell Malignancy | Phase 1 / Phase 2 | 2017-03-01 |